Hao Jiang

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The initial level of MLL-partial tandem duplication affects the clinical outcomes in patients with acute myeloid leukemia

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2018, Leukemia & lymphoma.

Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21).

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2016, Leukemia research.

S100A16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukaemia

Jiamin Zhang, Li-xin Wu, Jing Zhang, 2019, British journal of haematology.

Molecular responses of late chronic phase chronic myeloid leukemia patients after achieving complete cytogenetic responses with imatinib treatment: a 6-year follow-up

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2008, Annals of Hematology.

The Prognostic Significance of ZNF384 Fusions in Adult Ph-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: A Comprehensive Cohort Study From a Single Chinese Center

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2021, Frontiers in Oncology.

Profiles of NK cell subsets are associated with successful tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia and changes following interferon treatment

Ya-Zhen Qin, Hao Jiang, Xiao-jun Huang, 2021, Annals of Hematology.

Incidence, risk factors and outcomes of sinusoidal obstruction syndrome after haploidentical allogeneic stem cell transplantation

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2019, Annals of Hematology.

The prognostic significance of Wilms’ tumor gene 1 (WT1) expression at diagnosis in adults with Ph-negative B cell precursor acute lymphoblastic leukemia

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2019, Annals of Hematology.

Patients with AML-MRC benefit from decitabine in combination with low-dose G-CSF, cytarabine and aclarubicin: A single center cohort study

Hao Jiang, Jing Wang, J. Jia, 2022, Leukemia research reports.

Prognostic implications of the detection of measurable residual disease and mutations based on next‐generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA

Hao Jiang, G. Ruan, Jing Wang, 2022, British journal of haematology.

The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2021, Blood Cancer Journal.

Comparison of haplo-SCT and chemotherapy for young adults with standard-risk Ph-negative acute lymphoblastic leukemia in CR1

Hao Jiang, Q. Jiang, Yu Wang, 2020, Journal of Hematology & Oncology.

Prognostic value of RASD1 transcript levels in adult Philadelphia-negative B-cell acute lymphoblastic leukemia

Li-xin Wu, Jing Zhang, Ya-Zhen Qin, 2020, Hematology.

Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia

Hao Jiang, R. Gale, Hao Jiang, 2016, BMC Cancer.

The loss or absence of minimal residual disease of <0·1% at any time after two cycles of consolidation chemotherapy in CBFB–MYH11‐positive acute myeloid leukaemia indicates poor prognosis

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2020, British journal of haematology.

Detection of measurable residual disease may better predict outcomes than mutations based on next‐generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA

Hao Jiang, Q. Jiang, Yu Wang, 2020, British journal of haematology.

Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2015, Leukemia & lymphoma.

Helicobacter pylori infection influences the severity of thrombocytopenia and its treatment response in chronic hepatitis B patients with compensatory cirrhosis: A multicenter, observational study

Hao Jiang, Q. Jiang, Xiao-hui Zhang, 2016, Platelets.

Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial.

Saijuan Chen, Hao Jiang, Xiao-jun Huang, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk Stratification of Cytogenetically Normal Acute Myeloid Leukemia With Biallelic CEBPA Mutations Based on a Multi-Gene Panel and Nomogram Model

Li-xin Wu, Hao Jiang, Q. Jiang, 2021, Frontiers in Oncology.

Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant

Yan Liu, Hao Jiang, Q. Jiang, 2008, Acta Haematologica.

B-cell acute lymphoblastic leukemia associated with SET-NUP214 rearrangement: A case report and review of the literature.

Hao Jiang, Y. Lai, Honghu Zhu, 2016, Oncology letters.

A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data.

Hao Jiang, Q. Jiang, Xiao-hui Zhang, 2020, Blood advances.

Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study

Hao Jiang, Jianxiang Wang, A. Sun, 2020, Clinical Cancer Research.

All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP.

Hao Jiang, Q. Jiang, Xiao-hui Zhang, 2021, Blood.

Prediction of postpartum hemorrhage in pregnant women with immune thrombocytopenia: Development and validation of the MONITOR model in a nationwide multicenter study

Hao Jiang, Q. Jiang, Xiao-hui Zhang, 2021, American journal of hematology.

Superior survival of unmanipulated haploidentical hematopoietic stem cell transplantation compared with chemotherapy alone used as post-remission therapy in adults with standard-risk acute lymphoblastic leukemia in first complete remission.

Hao Jiang, Q. Jiang, Xiao-hui Zhang, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial.

Yu Wang, Huan Chen, Jin Lu, 2013, Blood.

The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission.

Hao Jiang, Q. Jiang, B. Jiang, 2012, Blood.

Prognostic significance of TIM-3 expression pattern at diagnosis in patients with t(8;21) acute myeloid leukemia

Hao Jiang, Q. Jiang, Yan-rong Liu, 2021, Leukemia & lymphoma.

CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutation.

Hao Jiang, Q. Jiang, B. Jiang, 2013, Leukemia research.

The predictive value of minimal residual disease when facing the inconsistent results detected by real-time quantitative PCR and flow cytometry in NPM1-mutated acute myeloid leukemia

Hao Jiang, Q. Jiang, Yan-rong Liu, 2019, Annals of Hematology.

Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics

R. Gale, Hao Jiang, Q. Jiang, 2017, Oncotarget.

Frontline flumatinib versus imatinib in patients with chronic myeloid leukemia in chronic phase: Results from the China randomized phase III study.

J. Gu, Hao Jiang, Jianxiang Wang, 2019, Journal of Clinical Oncology.

High EVI1 Expression Predicts Poor Outcomes in Adult Acute Myeloid Leukemia Patients with Intermediate Cytogenetic Risk Receiving Chemotherapy

Hao Jiang, Q. Jiang, Yan-rong Liu, 2018, Medical science monitor : international medical journal of experimental and clinical research.

Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms‐like tyrosine kinase 3 internal tandem duplication (FLT3‐ITD)

Ying Sun, Li-xin Wu, Hao Jiang, 2020, British journal of haematology.

The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia.

Hao Jiang, Q. Jiang, Xiao-jun Huang, 2018, Leukemia research.

Reduced medical costs and hospital days when using oral arsenic plus ATRA as the first-line treatment of acute promyelocytic leukemia.

Hao Jiang, Q. Jiang, Xiao-jun Huang, 2015, Leukemia research.

Tacrolimus Plus High-Dose Dexamethasone Versus High-Dose Dexamethasone Alone As First-Line Treatment for Adult Immune Thrombocytopenia: The Phase 2, Open Label, Randomized Trial (TARGET 020)

Hao Jiang, Q. Jiang, Yu-Hong Chen, 2021, Blood.

Treatment outcomes in relapsed acute promyelocytic leukemia patients initially treated with all-trans retinoic acid and arsenic compound-based combined therapies

Hao Jiang, B. Jiang, Xiaojun Huang, 2013, Oncology letters.

去甲氧柔红霉素10和8 mg/m2联合阿糖胞苷治疗初发急性髓系白血病的比较性研究

Hao Jiang, Q. Jiang, B. Jiang, 2015, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial.

Hao Jiang, Q. Jiang, Xiao-hui Zhang, 2017, The Lancet. Haematology.

[Change of PML/PML-RARalpha protein during treatment with tetraarsenic tetrasulfide (As4S4) in patients with acute promyelocytic leukemia].

Hao Jiang, Yan-rong Liu, L. Bao, 2003, Zhongguo shi yan xue ye xue za zhi.

Varying responses of PML-RARA with different genetic mutations to arsenic trioxide.

Hao Jiang, Q. Jiang, Xiao-jun Huang, 2015, Blood.

ADAM28 overexpression regulated via the PI3K/Akt pathway is associated with relapse in de novo adult B-cell acute lymphoblastic leukemia.

Hao Jiang, Q. Jiang, Xiao-hui Zhang, 2015, Leukemia research.

Heterogeneous prognosis among KIT mutation types in adult acute myeloid leukemia patients with t(8;21)

Hao Jiang, Q. Jiang, Yan-rong Liu, 2018, Blood Cancer Journal.

Prevalence and Prognostic Significance of c-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Comprehensive Large-Scale Study from a Single Chinese Center

Hao Jiang, Q. Jiang, B. Jiang, 2014 .

Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia

R. Gale, Hao Jiang, Q. Jiang, 2016, BMC Cancer.

Decitabine in patients with myelodysplastic syndromes: A multi‐center, open‐label, dose comparison trial

Hao Jiang, J. Ouyang, Hong-guo Zhao, 2023, Cancer medicine.

Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutations.

R. Gale, Hao Jiang, Q. Jiang, 2015, Leukemia research.

Monosomal karyotype is associated with poor outcomes in patients with Philadelphia chromosome–negative acute lymphoblastic leukemia receiving chemotherapy but not allogeneic hematopoietic stem cell transplantation

Hao Jiang, Q. Jiang, Yu Wang, 2020, Annals of Hematology.

Oral etoposide combined with oral arsenic plus retinoic acid for two cases with newly diagnosed high-risk acute promyelocytic leukemia during COVID19 pandemic

Hao Jiang, Ji-hong Zhu, R. Lou, 2021, Leukemia Research Reports.

[The efficacy of imatinib mesylate for 124 patients with chronic myeloid leukemia in accelerated and blastic phase].

Hao Jiang, Q. Jiang, B. Jiang, 2007, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[Efficacy and safety evaluation of imatinib in the treatment of patients with chronic granulocytic leukemia in accelerated phase].

Hao Jiang, Q. Jiang, B. Jiang, 2004, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy

Hao Jiang, Q. Jiang, B. Jiang, 2015, Leukemia & lymphoma.

Different kinetic patterns of BCR‐ABL transcript levels in imatinib‐treated chronic myeloid leukemia patients after achieving complete cytogenetic response

Hao Jiang, Xiao-jun Huang, G. Ruan, 2008, International journal of laboratory hematology.

Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisis

Hao Jiang, Q. Jiang, B. Jiang, 2014, Bone Marrow Transplantation.

成人Ph染色体阴性急性淋巴细胞白血病患者预后因素分析

Hao Jiang, Q. Jiang, B. Jiang, 2015, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Varying responses of PML-RARA with different genetic mutations to arsenic trioxide.

Hao Jiang, Q. Jiang, Xiao-jun Huang, 2015, Blood.

[Dasatinib treatment based on BCR- ABL mutation detection in imatinib- resistant patients with chronic myeloid leukemia].

Hao Jiang, Q. Jiang, Y. Lai, 2016, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutations.

R. Gale, Hao Jiang, Q. Jiang, 2015, Leukemia research.

Risk-Stratification Treatment Directed by Minimal Residual Disease Improves the Outcome of Acute Myeloid Leukemia with t(8;21) in First Complete Remission: Results of the AML05 Multicentre Trial

Hao Jiang, Q. Jiang, Xiao-hui Zhang, 2012 .